NVAX · Novavax Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-20 | DOUGLAS RICHARD |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
Common Stock
|
18,880 |
| 2026-06-20 | Alton Gregg H |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date |
Restricted Stock Units
|
18,880 |
| 2026-06-20 | MCGLYNN MARGARET G |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
Common Stock
|
18,880 |
| 2026-06-20 | DOUGLAS RICHARD |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date |
Restricted Stock Units
|
18,880 |
| 2026-06-20 | King Rachel K. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
Common Stock
|
18,880 |
| 2026-06-20 | MOTT DAVID M |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
Common Stock
|
18,880 |
| 2026-06-20 | Alton Gregg H |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
Common Stock
|
18,880 |
| 2026-06-20 | King Rachel K. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date |
Restricted Stock Units
|
18,880 |
| 2026-06-20 | MCGLYNN MARGARET G |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date |
Restricted Stock Units
|
18,880 |
| 2026-06-20 | MOTT DAVID M |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
18,880 |
| 2026-06-20 | Rodgers Richard J |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 20, 2025 grant date subject to continued service on the Company's Board of Directors through the vesting date |
Restricted Stock Units
|
18,880 |
| 2026-06-20 | Rodgers Richard J |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. |
Common Stock
|
18,880 |
| 2026-06-18 | Newton Charles W. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-06-18 | MCGLYNN MARGARET G |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | DOUGLAS RICHARD |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | DOUGLAS RICHARD |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-06-18 | Rodgers Richard J |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-06-18 | King Rachel K. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | MCGLYNN MARGARET G |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-06-18 | MOTT DAVID M |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | Rodgers Richard J |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | Shiver John W. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | Alton Gregg H |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | Alton Gregg H |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-06-18 | MOTT DAVID M |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-06-18 | King Rachel K. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-06-18 | Newton Charles W. |
Director |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Restricted Stock Units
|
14,180 |
| 2026-06-18 | Shiver John W. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. |
Stock Option (Right to Buy)
|
21,270 |
| 2026-04-25 | Newton Charles W. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock. The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of April 25, 2025, in each case subject to continued service on the Company's Board of Directors through such vesting date. |
Restricted Stock Units
|
9,520 |
| 2026-04-25 | Newton Charles W. |
Director |
Convert↑
|
Common Stock
|
9,520 |
| 2026-04-14 | Walker Robert Edward |
EVP, R&D |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. |
Stock Option (Right to Buy)
|
99,500 |
| 2026-04-14 | Walker Robert Edward |
EVP, R&D |
Award↑
Filing footnotes — Restricted Stock Units (Direct)
Each RSU represents a contingent right to receive one share of the "Company" common stock. The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the April 14, 2026 grant date, in each case subject to continued employment with the Company through such vesting date. |
Restricted Stock Units
|
66,000 |
| 2026-03-10 | Shiver John W. |
Director |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
The RSUs subject to this grant under the Restated 2015 Stock Incentive Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of March 10, 2025, in each case subject to continued service on the Company's Board of Directors through such vesting date |
Restricted Stock Units
|
7,947 |
| 2026-03-10 | Shiver John W. |
Director |
Convert↑
|
Common Stock
|
7,947 |
| 2026-03-07 | Kelly James Patrick |
EVP & Chief Financial Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date. |
Restricted Stock Units
|
12,223 |
| 2026-03-07 | Kelly James Patrick |
EVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
Common Stock
|
5,904 |
| 2026-03-07 | Kelly James Patrick |
EVP & Chief Financial Officer |
Convert↑
|
Common Stock
|
12,223 |
| 2026-03-03 | Kelly James Patrick |
EVP & Chief Financial Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
Common Stock
|
20,850 |
| 2026-03-03 | Kelly James Patrick |
EVP & Chief Financial Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date. |
Restricted Stock Units
|
43,167 |
| 2026-03-03 | Jacobs John C |
Director, PRESIDENT, CEO |
Convert↑
|
Common Stock
|
150,167 |
| 2026-03-03 | Casey Mark J |
EVP, Chief Legal Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
Common Stock
|
11,378 |
| 2026-03-03 | O'Hara Elaine |
EVP, Chief Strategy Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
Common Stock
|
22,429 |
| 2026-03-03 | Jacobs John C |
Director, PRESIDENT, CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
Common Stock
|
69,288 |
| 2026-03-03 | O'Hara Elaine |
EVP, Chief Strategy Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date. |
Restricted Stock Units
|
56,334 |
| 2026-03-03 | Casey Mark J |
EVP, Chief Legal Officer |
Convert↑
|
Common Stock
|
37,500 |
| 2026-03-03 | Casey Mark J |
EVP, Chief Legal Officer |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date. |
Restricted Stock Units
|
4,000 |
| 2026-03-03 | Kelly James Patrick |
EVP & Chief Financial Officer |
Convert↑
|
Common Stock
|
43,167 |
| 2026-03-03 | Jacobs John C |
Director, PRESIDENT, CEO |
Convert↓
Filing footnotes — Restricted Stock Units (Direct)
One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date. |
Restricted Stock Units
|
150,167 |
| 2026-03-03 | O'Hara Elaine |
EVP, Chief Strategy Officer |
Convert↑
|
Common Stock
|
56,334 |
| 2026-03-02 | Jacobs John C |
Director, PRESIDENT, CEO |
Award↑
Filing footnotes — Non-Statutory Stock Option NQ (Direct)
This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing. One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. |
Non-Statutory Stock Option NQ
|
551,500 |